Rapid Micro Biosystems Future Growth
Future criteria checks 2/6
Rapid Micro Biosystems is forecast to grow earnings and revenue by 10.4% and 27.3% per annum respectively. EPS is expected to grow by 17.7% per annum. Return on equity is forecast to be -66.6% in 3 years.
Key information
10.4%
Earnings growth rate
17.7%
EPS growth rate
| Life Sciences earnings growth | 16.3% |
| Revenue growth rate | 27.3% |
| Future return on equity | -66.6% |
| Analyst coverage | Low |
| Last updated | 06 May 2024 |
Recent future growth updates
Recent updates
We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
Jun 30
Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing
Oct 10Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth
May 09Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67
Mar 08We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
Feb 07Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 51 | -38 | N/A | N/A | 1 |
| 12/31/2025 | 37 | -44 | N/A | N/A | 3 |
| 12/31/2024 | 27 | -47 | N/A | N/A | 3 |
| 3/31/2024 | 23 | -52 | -46 | -44 | N/A |
| 12/31/2023 | 23 | -52 | -47 | -45 | N/A |
| 9/30/2023 | 21 | -58 | -49 | -47 | N/A |
| 6/30/2023 | 19 | -61 | -56 | -53 | N/A |
| 3/31/2023 | 18 | -60 | -64 | -58 | N/A |
| 12/31/2022 | 17 | -61 | -65 | -59 | N/A |
| 9/30/2022 | 18 | -59 | -68 | -60 | N/A |
| 6/30/2022 | 20 | -68 | -71 | -64 | N/A |
| 3/31/2022 | 22 | -69 | -66 | -61 | N/A |
| 12/31/2021 | 23 | -78 | -58 | -55 | N/A |
| 9/30/2021 | 23 | -77 | -49 | -47 | N/A |
| 6/30/2021 | 22 | -63 | -38 | -37 | N/A |
| 3/31/2021 | 18 | -60 | -35 | -34 | N/A |
| 12/31/2020 | 16 | -45 | -32 | -31 | N/A |
| 12/31/2019 | 17 | -27 | -23 | -21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RPID is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RPID is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RPID is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RPID's revenue (27.3% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: RPID's revenue (27.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RPID is forecast to be unprofitable in 3 years.